Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Non-random chromosomal deletion clustering at 20q in Waldenström macroglobulinemia.

Kitahara T, Umezu T, Ando K, Kodama A, Ohyashiki JH, Ohyashiki K.

Hematology. 2011 May;16(3):139-42. doi: 10.1179/102453311X12953015767338.

PMID:
21669052
2.

Deletion (20q) as the sole abnormality in Waldenström macroglobulinemia suggests distinct pathogenesis of 20q11 anomaly.

Liu YC, Miyazawa K, Sashida G, Kodama A, Ohyashiki K.

Cancer Genet Cytogenet. 2006 Aug;169(1):69-72.

PMID:
16875940
3.

Interstitial deletion of 20q in a patient with Waldenström macroglobulinemia following chemotherapy.

Blann MM, Velagaleti GV, Morgan DL, Martinez RE, Conlin PA, Tonk VS.

Cancer Genet Cytogenet. 2002 Jan 15;132(2):145-8.

PMID:
11850077
4.

Frequency, hematopathology, and detection of a new isodicentric variant of deletion 20q.

Smoley SA, Fink SR, Paternoster SF, Stockero KJ, Nguyen LP, Nguyen PL, Hanson CA, Dewald GW.

Cancer Genet Cytogenet. 2007 Mar;173(2):144-9.

PMID:
17321330
5.

Prognostic significance of del(20q) in patients with hematological malignancies.

Brezinová J, Zemanová Z, Ransdorfová S, Sindelárová L, Sisková M, Neuwirtová R, Cermák J, Michalová K.

Cancer Genet Cytogenet. 2005 Jul 15;160(2):188-92.

PMID:
15993278
6.

Molecular cytogenetic analysis of Korean patients with Waldenström macroglobulinemia.

Bang SM, Seo JW, Park KU, Kim SJ, Kim K, Kim SH, Cho SR, Kim HC, Song J, Kim JS, Kim KH, Lee JH, Lee JJ, Shin MG, Suh C, Chi HS, Oh DY, Won JH, Kim HJ, Yoon SS, Lee DS; Korean Multiple Myeloma Working Party (KMMWP)..

Cancer Genet Cytogenet. 2010 Mar;197(2):117-21. doi: 10.1016/j.cancergencyto.2009.11.008.

PMID:
20193844
7.

Deletion(20q) as the sole abnormality in plasma cell myeloma is not associated with plasma cells as identified by cIg FISH.

White JS, Zordan A, Batzios C, Campbell LJ.

Cancer Genet. 2012 Dec;205(12):644-52. doi: 10.1016/j.cancergen.2012.10.007. Epub 2012 Nov 30.

PMID:
23200818
8.

Interphase FISH does not improve the detection of DEL(5q) and DEL(20q) in myelodysplastic syndromes.

Douet-Guilbert N, Herry A, LE Bris MJ, Guéganic N, Bovo C, Morel F, DE Braekeleer M.

Anticancer Res. 2011 Mar;31(3):1007-10.

PMID:
21498729
9.

[Clinical and molecular cytogenetic features of myeloid diseases characterized by i(20q-): a study of seven cases].

Li TY, Xue YQ, Wu YF, Pan JL, Liu DD, Gong SL.

Zhonghua Yi Xue Za Zhi. 2004 May 2;84(9):732-5. Chinese.

PMID:
15200909
10.

Characterization of 20q deletions in patients with myeloproliferative disorders or myelodysplastic syndromes.

Nacheva E, Holloway T, Carter N, Grace C, White N, Green AR.

Cancer Genet Cytogenet. 1995 Apr;80(2):87-94.

PMID:
7736443
11.
12.

FISH studies identify the i(20q-) anomaly as a der(20)del(20)(q11q13)idic(20)(p11).

Li T, Xue Y, Wu Y, Pan J.

Genes Chromosomes Cancer. 2006 Jun;45(6):536-9.

PMID:
16506189
13.

Microarray CGH analysis of hematological patients with del(20q).

Wu C, Pan J, Qiu H, Xue Y, Chen S, Wu Y, zhang J, Bai S, Wang Y, Shen J, Gong Y.

Int J Hematol. 2015 Nov;102(5):617-25. doi: 10.1007/s12185-015-1872-3. Epub 2015 Oct 6.

PMID:
26440974
14.

Microarray CGH analyses of chromosomal 20q deletions in patients with hematopoietic malignancies.

Okada M, Suto Y, Hirai M, Shiseki M, Usami A, Okajima K, Teramura M, Mori N, Motoji T.

Cancer Genet. 2012 Jan-Feb;205(1-2):18-24. doi: 10.1016/j.cancergen.2011.12.002.

PMID:
22429594
15.

Refinement of the commonly deleted segment in myeloid leukemias with a del(20q).

Wang PW, Iannantuoni K, Davis EM, Espinosa R 3rd, Stoffel M, Le Beau MM.

Genes Chromosomes Cancer. 1998 Feb;21(2):75-81.

PMID:
9491317
16.

Different mechanisms lead to a karyotypically identical t(20;21) in myelodysplastic syndrome and in acute myelocytic leukemia.

Matteucci C, La Starza R, Crescenzi B, Romoli S, Santoro A, Magrin S, Lauria F, Coco FL, Martelli MF, Mecucci C.

Cancer Genet Cytogenet. 2003 Jan 1;140(1):13-7.

PMID:
12550752
17.

[Report of ten cases of hematologic malignancies with idic(20q-) and literature review].

Han YS, Xue YQ, Li TY, Zhang J, Chen SN, Pan JL, Wu YF, Wang Y, Shen J.

Zhonghua Xue Ye Xue Za Zhi. 2011 Jan;32(1):17-20. Review. Chinese.

PMID:
21429395
18.

Chromosome 20q deletion: a recurrent cytogenetic abnormality in patients with chronic myelogenous leukemia in remission.

Sun J, Yin CC, Cui W, Chen SS, Medeiros LJ, Lu G.

Am J Clin Pathol. 2011 Mar;135(3):391-7. doi: 10.1309/AJCPQFSC9ZJNMAZ6.

PMID:
21350093
19.

Clinical and molecular cytogenetic studies in ten patients with hematological malignancies characterized by t(20;21)(q11;q11) resulted from del(20q).

Wu C, Zhang J, Bai S, Yao J, Qiu H, Xue Y, Chen S, Wu Y, Shen J, Pan J.

Cancer Genet. 2016 Oct;209(10):456-462. doi: 10.1016/j.cancergen.2016.09.006. Epub 2016 Sep 19.

PMID:
27810074

Supplemental Content

Support Center